articleCirculation JournalJan 1, 2004BRONZE OA

Adiponectin as a Biomarker of the Metabolic Syndrome

Osaka University · Sumitomo Hospital

PubMed
Indexed incrossrefpubmed

Abstract

BACKGROUND: The metabolic syndrome, a cluster of abdominal obesity, dyslipidemia, hypertension and hyperglycemia, is a common basis for atherosclerotic vascular diseases in industrial countries exposed to overnutrition. Adiponectin is an adipose-derived plasma protein with anti-atherogenic and insulin-sensitizing activities. METHODS AND RESULTS: A total of 661 Japanese adults (479 men, 53+/-10 years; 182 women 56+/-10 years) were enrolled. Plasma adiponectin concentrations correlated negatively with waist circumference, visceral fat area, serum triglyceride concentration, fasting plasma glucose, fasting plasma insulin, and systolic and diastolic blood pressure in both sexes. A positive correlation was found…

Citation impact

763
total citations
FWCI
23.36
Percentile
100%
References
47
Citations per year

Authors

9

Topics & keywords

Keywords
  • Adiponectin
  • Internal medicine
  • Endocrinology
  • Metabolic syndrome
  • Medicine
  • Dyslipidemia
  • Abdominal obesity
  • Waist
UN Sustainable Development Goals
  • Zero hunger
No related works found for this paper.